Who should decide if a drug is worth the cost?

With our new President in office, the debate continues about America's seemingly unlimited spending on prescription medications and the best ways to control healthcare costs. Scott Gottlieb wrote an op-ed in the Wall Street Journal opposing the strategies he sees President Obama and the new administration considering to solve the problem.  Report.